Disease Markers / 2018 / Article / Tab 1

Research Article

EWSR1 Rearrangement and CD99 Expression as Diagnostic Biomarkers for Ewing/PNET Sarcomas in a Moroccan Population

Table 1

Clinical features of enrolled 41 EPS cases.

Case numberAge and sexAnatomic siteEWSR1 gene rearrangementCD99 staining

126/MAbdomen+++
237/MLower limbs+
310/FHead and neck++++
440/FLower limbs++
514/MSoft tissue+++
616/MUpper limbs+
719/MLower limbs++
810/MLower limbs+
98/FLower limbs++++
1019/MLower limbs++++
1110/MPelvis+
1213/MUpper limbs++++
1338/MPelvis+++
146/FPelvisIN+++
1519/FUpper limbs++++
168/MLower limbs++++
1718/MAbdomen+++
185/MThorax++++
199/FLower limbs++++
2015/MLower limbs+++
2122/MThorax+++
2211/MSoft tissue+++
2323/FThorax++++
2417/MThorax++++
256/FThorax+++
2621/MSoft tissue+++
2718/MLower limbsIN+
2821/FPelvis++++
2962/FAbdomen+
3028/FSoft tissue+++
3129/MAbdomen
3214/MLower limbs++++
3325/MUpper limbs++++
343/MLower limbs++++
3529/MPelvis++++
3628/MSoft tissue+++
3750/FSoft tissue++++
3840/MThorax+
3962/FUpper limbs+
4037/MThorax
4121/FAbdomen++++

For EWSR1 rearrangement: positive (+), negative (−), and inconclusive (IN); for CD9 immunostaining: positive staining < 50% (+) and strong, diffuse, and membranous staining ≥ 50% (+++).

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.